Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gigantol is a bibenzyl phenolic compound primarily extracted from plants in the genus Dendrobium, particularly from the stem of Dendrobium aurantiacum and other medicinal orchids. It is used in traditional Chinese medicine and has demonstrated multiple bioactivities including anticancer, anti-osmotic, antimutagenic, and immunomodulatory properties. The compound has shown promising therapeutic potential against various cancer types, particularly lung cancer and hepatocellular carcinoma. Gigantol exerts its anticancer effects through multiple mechanisms including inhibition of the PI3K/Akt/NF-κB signaling pathway, suppression of the Wnt/β-catenin pathway, induction of apoptosis, and reduction of cancer stem cell-like phenotypes. It has also been reported to inhibit aldose reductase and shows potential as a neuroprotective agent. The molecular formula is C16H18O4 with a molecular weight of 274.31 g/mol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gigantol.